Evidence map›Paper›PMID 30702577›Full record

Observational studyMedicine2019

Risk of massive blood product requirement in cardiac surgery: A large retrospective study from 2 heart centers.

Dou Huang, Changwei Chen, Yue Ming, Jing Liu, Li Zhou, Fengjiang Zhang, Min Yan, Lei Du

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Anemia and Transfusion in Infective Endocarditis.Reviews in cardiovascular medicine · 2025
    Review
  3. Article
  4. Article
  5. Perioperative Complications in Infective Endocarditis.Journal of clinical medicine · 2023
    Review
  6. Comment on "Association of Intraoperative Red Blood Cell Transfusions With Venous Thromboembolism and Adverse Outcomes After Cardiac Surgery".Annals of surgery open : perspectives of surgical history, education, and clinical approaches · 2023
    Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Dou HuangDepartment of Anesthesiology and Translational Center, West China Hospital, Sichuan University, Chengdu, Sichuan.
Changwei ChenDepartment of Anesthesiology and Translational Center, West China Hospital, Sichuan University, Chengdu, Sichuan.
Yue MingDepartment of Anesthesiology, The Second Affiliated Hospital, Zhejiang University, Hangzhou, Zhejiang, China.
Jing LiuDepartment of Anesthesiology and Translational Center, West China Hospital, Sichuan University, Chengdu, Sichuan.
Li ZhouDepartment of Anesthesiology and Translational Center, West China Hospital, Sichuan University, Chengdu, Sichuan.
Fengjiang ZhangDepartment of Anesthesiology, The Second Affiliated Hospital, Zhejiang University, Hangzhou, Zhejiang, China.
Min YanDepartment of Anesthesiology, The Second Affiliated Hospital, Zhejiang University, Hangzhou, Zhejiang, China.
Lei DuDepartment of Anesthesiology and Translational Center, West China Hospital, Sichuan University, Chengdu, Sichuan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiac surgery under cardiopulmonary bypass (CPB) accounts for most consumption of red blood cells (RBCs). Identifying risk factors for massive red blood cell transfusion (MRT) in cardiac surgery may help to reduce this consumption.We retrospectively analyzed 8238 patients who underwent valve surgery and/or coronary artery bypass grafting (CABG) under CPB at 2 major heart centers in China. Uni- and multivariate logistic regression was carried out to assess whether risk factors for MRT (defined as receiving at least 4 units RBCs) varied with type of cardiac surgery.A total of 1691 patients (21%) received at least 4 units RBCs (6.77 ± 4.78 units per person). This MRT group consumed 70% of the total units of allogeneic RBCs in the study. MRT incidence was 2-fold higher among patients undergoing CABG with or without valve surgery than among patients undergoing valve surgery alone. Multivariate logistic analysis identified the following MRT risk factors common to valve surgery alone, CABG alone, and their combination: female sex, older age, renal dysfunction, lower body mass index, lower preoperative hemoglobin, and longer CPB. Several independent MRT risk factors were also identified specific to valve surgery: active endocarditis, nonatrial fibrillation, smaller left atrium diameter, abnormal international normalized ratio, and repeat surgery.Different types of cardiac surgery share several, but not all, MRT risk factors. This study may help guide the prediction and management of patients at higher MRT risk.

Indexed as

Age FactorsBody Mass IndexComorbidityCoronary Artery BypassErythrocyte TransfusionFemaleHeart Valve Prosthesis ImplantationHemoglobinsHumansKidney Function TestsLogistic ModelsMaleOperative TimeRetrospective StudiesRisk FactorsSex FactorsHemoglobins

Identifiers

PMID30702577
PMCPMC6380710

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.